Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, Novavax Inc maintains a gross margin of 69.49%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -112.68%, while the net margin is -287.29%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively NVAX converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, NVAX competes directly with industry leaders such as KMDA and ELVN. With a market capitalization of $1.52B, it holds a leading position in the sector. When comparing efficiency, NVAX's gross margin of 69.49% stands against KMDA's 42.04% and ELVN's N/A. Such benchmarking helps identify whether Novavax Inc is trading at a premium or discount relative to its financial performance.
